MacroGenics former officer proposes 17K-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MacroGenics, Inc. former officer Thomas Spitznagel reported a proposed sale of 17,000 common shares, with an aggregate market value of $75,529 and an approximate sale date of July 13, 2026. The shares are listed as acquired from the issuer through stock plan activity on July 13, 2026.
Key Figures
Key Terms
Aggregate Market Value financial
Stock Plan Activity financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.